Do All Integrase Strand Transfer Inhibitors Have the Same Lipid Profile? Review of Randomised Controlled Trials in Naïve and Switch Scenarios in HIV-Infected Patients
In this study, we aim to explore the effects on lipids of integrase strand transfer inhibitors (INSTIs) in naïve and switch randomised controlled trials, and compare them with protease inhibitors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs). We reviewed phase 3/4 randomised cli...
Main Authors: | Maria Saumoy, Jose Luís Sanchez-Quesada, Jordi Ordoñez-Llanos, Daniel Podzamczer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/16/3456 |
Similar Items
-
Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
by: Linda A. Mandikiyana Chirimuta, et al.
Published: (2022-10-01) -
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
by: Emma G. Foster, et al.
Published: (2022-12-01) -
Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors
by: Emma G. Foster, et al.
Published: (2023-02-01) -
Potential drug–drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan
by: Yusuke Kunimoto, et al.
Published: (2021-12-01) -
Pharmacokinetic drug interactions of integrase strand transfer inhibitors
by: Chi-Hua Lu, et al.
Published: (2021-01-01)